Skripko V D, Kovalenko A L, Zaplutanov V A
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
Toxicology Institute of the Federal Medical and Biological Agency, St. Ptersburg, Russia.
Khirurgiia (Mosk). 2017(8):75-78. doi: 10.17116/hirurgia2017875-78.
The aim of the study was to evaluate the effectiveness of cytoflavin in the complex treatment of patients with diabetic foot syndrome.
The research is based on the results of a comprehensive survey of 140 people with diabetic foot syndrome. Depending on the treatment, all patients were divided into 2 groups. The first group (n=35) received basic therapy. The second group (n=35) in addition to basic therapy received cytoflavin 10 ml (+200 ml 0.9% NaCl) for 10 days, followed by switching to the tablet form of the drug 2 tablets twice a day for 1 month.
Analyzing the severity of polyneuropathy after treatment, we noted a more positive dynamic in patients who in addition to standard therapy received cytoflavin.
